Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trialParesh Dandona, Bertrand Cariou, Chantal Mathieu et al.|The Lancet Diabetes & Endocrinology|2017Cited by 295
No correlation between carotid intima-media thickness and long-term glycemic control in individuals with type 1 diabetesJussi Inkeri, P. Kääriäinen, Per‐Henrik Groop et al.|Acta Diabetologica|2023Cited by 2